Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

QR Code

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice

Rafael Campos Polo, Consuelo Rubio Sánchez, Diego Manuel García Guisado, María José Díaz Luque Unit of Retina, Department of Ophthalmology, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain Purpose: To assess the effectiveness a...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Campos Polo R, Rubio Sánchez C, Garcia Guisado DM, Díaz Luque MJ
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	Aflibercept · Central macular thickness · Diabetic macular edema · Routine clinical practce · Visual acuity Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/6e34b3584c21494d9fee47e4d8372bf9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
par: Nixon DR, et autres
Publié: (2018)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
par: Xiu-Xian Wang, et autres
Publié: (2021)

Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
par: Kern C, et autres
Publié: (2020)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
par: Tran THC, et autres
Publié: (2021)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
par: Pessoa B, et autres
Publié: (2021)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
par: Paulose R, et autres
Publié: (2016)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
par: Chen YX, et autres
Publié: (2020)

Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
par: Rodolfo Mastropasqua, et autres
Publié: (2018)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
par: Oellers P, et autres
Publié: (2016)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
par: Tagami M, et autres
Publié: (2017)

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
par: Veritti D, et autres
Publié: (2021)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
par: Patel PJ, et autres
Publié: (2017)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
par: Udaondo P, et autres
Publié: (2021)

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
par: Chiara Altana, et autres
Publié: (2021)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
par: Ren Aoki, et autres
Publié: (2021)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
par: Van Aken E, et autres
Publié: (2020)

Subfoveal choroidal thickness in diabetic macular edema
par: Mohamed DM, et autres
Publié: (2019)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
par: Dugel PU, et autres
Publié: (2016)

Pseudophakic cystoid macular edema: update 2016
par: Grzybowski A, et autres
Publié: (2016)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
par: Ume Sughra, et autres
Publié: (2021)

Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample
par: Lehmann R, et autres
Publié: (2021)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2017)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
par: Dweikat A, et autres
Publié: (2021)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
par: Sakamoto S, et autres
Publié: (2018)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
par: M. M. Bikbov, et autres
Publié: (2016)

Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment Costs
par: Ramsey DJ, et autres
Publié: (2021)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
par: Andrzej Grzybowski, et autres
Publié: (2021)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
par: Takeyama M, et autres
Publié: (2017)

Rebound macular edema following oral acetazolamide therapy for juvenile X-linked retinoschisis in an Italian family
par: Galantuomo MS, et autres
Publié: (2016)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
par: Wei W, et autres
Publié: (2021)

Primary treatment of diabetic macular edema
par: Tushar M Ranchod, et autres
Publié: (2009)

CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC MACULAR EDEMA
par: Amash Aqil, et autres
Publié: (2021)

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
par: Spooner K, et autres
Publié: (2017)

Diagnostic Criteria for Macular Edema Associated with Venous Occlusions
par: A. G. Shchuko, et autres
Publié: (2020)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
par: Amy S. Babiuch, et autres
Publié: (2021)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
par: Khanani AM, et autres
Publié: (2019)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
par: Kiire CA, et autres
Publié: (2015)